National Medical Care Company

SASE:4005 Rapporto sulle azioni

Cap. di mercato: ر.س7.4b

National Medical Care Performance dei guadagni passati

Il passato criteri di controllo 2/6

National Medical Care ha registrato una crescita degli utili a un tasso medio annuo di 27.1%, mentre il settore Healthcare ha registrato utili in crescita a un tasso medio annuo di 14%. I ricavi sono stati in crescita a un tasso medio annuo di 11.9%. Il ritorno sul capitale proprio di National Medical Care è 18.5% e ha margini netti di 21.9%.

Informazioni chiave

27.11%

Tasso di crescita degli utili

27.15%

Tasso di crescita dell'EPS

Healthcare Crescita del settore12.28%
Tasso di crescita dei ricavi11.93%
Rendimento del capitale proprio18.55%
Margine netto21.89%
Ultimo aggiornamento sui guadagni31 Mar 2025

Aggiornamenti sulle prestazioni recenti

We Think You Should Be Aware Of Some Concerning Factors In National Medical Care's (TADAWUL:4005) Earnings

May 18
We Think You Should Be Aware Of Some Concerning Factors In National Medical Care's (TADAWUL:4005) Earnings

National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

Oct 29
National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

Recent updates

We Think You Should Be Aware Of Some Concerning Factors In National Medical Care's (TADAWUL:4005) Earnings

May 18
We Think You Should Be Aware Of Some Concerning Factors In National Medical Care's (TADAWUL:4005) Earnings

National Medical Care (TADAWUL:4005) Is Paying Out A Dividend Of SAR2.00

May 15
National Medical Care (TADAWUL:4005) Is Paying Out A Dividend Of SAR2.00

National Medical Care (TADAWUL:4005) Will Pay A Dividend Of SAR2.00

Apr 24
National Medical Care (TADAWUL:4005) Will Pay A Dividend Of SAR2.00

Risks To Shareholder Returns Are Elevated At These Prices For National Medical Care Company (TADAWUL:4005)

Mar 21
Risks To Shareholder Returns Are Elevated At These Prices For National Medical Care Company (TADAWUL:4005)

National Medical Care (TADAWUL:4005) Might Have The Makings Of A Multi-Bagger

Jan 30
National Medical Care (TADAWUL:4005) Might Have The Makings Of A Multi-Bagger

If EPS Growth Is Important To You, National Medical Care (TADAWUL:4005) Presents An Opportunity

Jan 08
If EPS Growth Is Important To You, National Medical Care (TADAWUL:4005) Presents An Opportunity

What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

Dec 12
What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

Oct 29
National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Sep 25
National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Aug 06
Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

Jul 26
Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

Apr 05
National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

Mar 14
We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Mar 13
National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Dec 27
Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

Dec 05
Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Aug 07
We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

May 29
Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

May 08
Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Dec 19
Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Oct 19
A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

Aug 15
National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

May 13
National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 03
Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Feb 10
A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Nov 10
Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

Jul 02
Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Apr 14
Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Mar 25
Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Feb 23
Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

Feb 09
Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 27
National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Jan 14
Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Dec 25
Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 10
Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Nov 24
What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Ripartizione dei ricavi e delle spese

Come National Medical Care guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

SASE:4005 Ricavi, spese e utili (SAR Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
31 Mar 251,3803022000
31 Dec 241,2942982000
30 Sep 241,2212741740
30 Jun 241,1712881500
31 Mar 241,1192661320
31 Dec 231,0822411240
30 Sep 231,034233940
30 Jun 239972021100
31 Mar 239681961030
31 Dec 22918170980
30 Sep 228821511040
30 Jun 22857142940
31 Mar 22843131930
31 Dec 21845136880
30 Sep 21844122990
30 Jun 218451051040
31 Mar 218281001130
31 Dec 20809971070
30 Sep 2078095860
30 Jun 2074095780
31 Mar 2072483720
31 Dec 1970880730
30 Sep 1970565730
30 Jun 1970760720
31 Mar 1973767760
31 Dec 1876462810
30 Sep 1881081920
30 Jun 1884296920
31 Mar 1885995960
31 Dec 17855851000
30 Sep 17817-81250
30 Jun 17806-71260
31 Mar 17849331190
31 Dec 16901501240
30 Sep 16931155900
30 Jun 16945153910
31 Mar 16913136950
31 Dec 15879131870
30 Sep 15853106960
30 Jun 15820102940
31 Mar 1577291940
31 Dec 1473495810
30 Sep 14703106700
30 Jun 14660103580

Guadagni di qualità: 4005 ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di 4005 (21.9%) sono inferiori rispetto allo scorso anno (23.8%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di 4005 sono cresciuti in modo significativo del 27.1% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di 4005 nell'ultimo anno ( 13.6% ) è inferiore alla media quinquennale ( 27.1% all'anno).

Guadagni vs Settore: La crescita degli utili 4005 nell'ultimo anno ( 13.6% ) non ha superato quella del settore Healthcare 18.7%.

Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 18.5% ) di 4005 è considerato basso.

Rendimento delle attività

Rendimento del capitale investito

Scoprire le aziende con forti performance passate

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2025/05/19 15:55
Prezzo dell'azione a fine giornata2025/05/19 00:00
Guadagni2025/03/31
Guadagni annuali2024/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

National Medical Care Company è coperta da 11 analisti. 8 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Jassim Al-JubranAljazira Capital Company
Ibrahim ElaiwatAljazira Capital Company
Madhu AppissaAl Rajhi Capital